Company’s Contract Research Organization in order to assist the Company in determining what would be the most efficient actions to undertake in order to commercialize the Company’s NR2F6 intellectual property as well as assist the Company with regulatory strategy with regard to the Company’s NR2F6 intellectual property
Still believing in your assessment of RGBP, OTCSC! IF Lilly is the buy-out or merger company, what will RGBP's PPS be when this happens? Thank you for your input~